SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Genstar GNT(formerly UroGen)-- an interesting speculation -- Ignore unavailable to you. Want to Upgrade?

To: Paul Lee who wrote (81)7/12/2001 1:57:45 AM
From: SnowShredder  Respond to of 100
 
transient liver chemistries and hematologic abnormalities were
observed from an analysis of the patient's blood. While some of these
laboratory abnormalities were severe, these laboratory values returned to
normal shortly thereafter...suffered a
spontaneous joint bleed at the time of the laboratory abnormalities

Too bad they didn't elaborate on this. Do you know if the protocol for the trial is posted anywhere? Thanks.

Best of Luck,

WHG?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News